HOAG ORTHOPEDIC INSTITUTE — History
CCN 050769 | 3-year financial timeline | COVID resilience: 67/100
🛡️ Public data only — no PHI permitted on this instance.
$151M
Latest Revenue (FY2022)
+7.8%
Revenue CAGR (3yr)
31.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $130M | $144M | $151M | +4.8% | +7.8% |
| Operating Expenses | $94M | $104M | $104M | +0.1% | +4.9% |
| Operating Margin | 27.2% | 27.8% | 31.1% | +11.8% | +6.9% |
| Net Income | $35M | $40M | $47M | +17.1% | +15.3% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 5,193 | 4,744 | 4,523 | -4.7% | -6.7% |
| Medicare Day % | 43% | 40% | 46% | +16.0% | +3.8% |
| Medicaid Day % | 0% | 1% | 0% | -92.2% | -42.7% |
COVID Impact & Recovery
Resilience Score: 67/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.2% ($130M → $151M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+7.8%
This Hospital
+7.6%
State Avg
Latest Margin
31.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $161M | 33.1% |
| FY2024 (proj) | $172M | 35.0% |
| FY2025 (proj) | $182M | 37.0% |